Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Oct 17:1-13. doi: 10.1080/03602532.2023.2271195. Online ahead of print.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-t...
Source: Drug Metabolism Reviews - October 18, 2023 Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
Biotransformation research advances - 2022 year in review
Drug Metab Rev. 2023 Sep 22:1-42. doi: 10.1080/03602532.2023.2262161. Online ahead of print.ABSTRACTThis annual review is the eighth of its kind since 2016 (Baillie et al. 2016, Khojasteh et al. 2017, Khojasteh et al. 2018, Khojasteh et al. 2019, Khojasteh et al. 2020, Khojasteh et al. 2021, Khojasteh et al. 2022). Our objective is to explore and share articles which we deem influential and significant in the field of biotransformation.PMID:37737116 | DOI:10.1080/03602532.2023.2262161 (Source: Drug Metabolism Reviews)
Source: Drug Metabolism Reviews - September 22, 2023 Category: Drugs & Pharmacology Authors: S Cyrus Khojasteh Upendra A Argikar Lionel Cheruzel Sungjoon Cho Rachel D Crouch Deepika Dhaware Carley J S Heck Kevin M Johnson Amit S Kalgutkar Lloyd King Joyce Liu Bin Ma Hlaing Maw Grover P Miller Herana Kamal Seneviratne Ryan H Takahashi Shuai Wang C Source Type: research
